Latest news
BI-1808 Receives FDA Fast Track Designation in Ovarian Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 20:14:04 GMTFDA advisers backed Replimune's RP1 melanoma therapy,… - inklinkl · Tue, 04 Aug 2026 05:28:13 GMTFDA Tells Cancer Trial Sponsors to Stop Copying Eligibility Rules That Lack Scientific Support - Medical DailyMedical Daily · Tue, 04 Aug 2026 02:00:04 GMTThe F.D.A. Could Clear These Peptides. Here’s What the Research on Them Shows. - The New York TimesThe New York Times · Mon, 27 Jul 2026 07:00:00 GMT